Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.kilpest.com | |
Market Cap | 304.83 Cr. | |
Enterprise Value(EV) | 272.19 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 29.70 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 13.80 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 19.66 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 224.24 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 1.83 | Calculated using Price: 410.00 |
Dividend Yield | 0.62 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.75 Cr. | 7,508,100 Shares |
FaceValue | 10 | |
Company Profile | ||
Kilpest India is one of India's leading agri-based companies. Kilpest is an ISO certified company and has representation in India in the field of agriculture business comprising crop protection products and public health products, bio products, micro-nutrients and mix fertilizers. The company has one of the most advance Research & Development facility at its Bhopal plant and also has Biological Research Centre. The products are manufactured to high international! BlS specifications with stringent quality control from raw material procurement to finished goods despatch. |
1 Day |
|
+0.85% |
1 Week |
|
-0.71% |
1 Month |
|
-2.08% |
3 Month |
|
-12.93% |
6 Month |
|
+15.64% |
1 Year |
|
+9.71% |
2 Year |
|
+38.12% |
5 Year |
|
+213.22% |
10 Year |
|
+4548.53% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 3.86 | 2.33 | 3.26 | 10.47 | 27.55 | 28.99 | 28.15 | 138.73 | 22.59 | |
Return on Capital Employed (%) | 6.97 | 6.60 | 6.80 | 12.52 | 23.80 | 28.04 | 32.29 | 179.46 | 29.92 | |
Return on Assets (%) | 1.62 | 0.96 | 1.37 | 4.55 | 12.22 | 15.71 | 18.94 | 95.54 | 16.70 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 10 | 10 | 10 | 11 | 18 | 23 | 32 | 132 | 153 | 161 | |
Non Curr. Liab. | 3 | 3 | 3 | 4 | 3 | 3 | 2 | 2 | 3 | 3 | |
Curr. Liab. | 11 | 12 | 10 | 11 | 9 | 10 | 8 | 43 | 17 | 20 | |
Minority Int. | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 16 | 19 | 23 | |
Equity & Liab. | 24 | 25 | 24 | 26 | 30 | 36 | 45 | 194 | 192 | 207 | |
Non Curr. Assets | 4 | 4 | 4 | 4 | 4 | 4 | 6 | 75 | 111 | 112 | |
Curr. Assets | 20 | 21 | 21 | 22 | 26 | 32 | 39 | 118 | 82 | 95 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 24 | 25 | 24 | 26 | 30 | 36 | 45 | 194 | 192 | 207 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 22 | 19 | 17 | 16 | 23 | 23 | 29 | 227 | 81 | 62 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 7 | 8 | |
Total Income | 22 | 19 | 17 | 16 | 23 | 24 | 30 | 230 | 88 | 70 | |
Total Expenditure | -21 | -18 | -16 | -14 | -18 | -16 | -20 | -77 | -44 | -35 | |
PBIDT | 1 | 1 | 2 | 3 | 6 | 8 | 11 | 153 | 44 | 36 | |
Interest | -1 | -1 | -1 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | 0 | -1 | -2 | -2 | -38 | -11 | -9 | |
Exceptional Items | 0 | ||||||||||
PAT | 0 | 0 | 0 | 1 | 3 | 5 | 8 | 114 | 32 | 26 | |
Minority Interest | 0 | 0 | 0 | -3 | |||||||
Share Associate | |||||||||||
Other Related Items | 0 | ||||||||||
Consolidated Net Profit | 1 | 0 | 0 | 1 | 3 | 5 | 8 | 114 | 32 | 22 | |
Adjusted EPS | 1 | 1 | 1 | 2 | 5 | 8 | 10 | 152 | 43 | 30 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -1 | 0 | 0 | 1 | 1 | 2 | 4 | 7 | 98 | 37 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -70 | -28 | |
Cash Fr. Finan. | 0 | 0 | 0 | -1 | 0 | 0 | -1 | 1 | -2 | -15 | |
Net Change | -1 | 0 | 0 | 0 | 1 | 2 | 7 | 26 | -6 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 9 | 35 | 29 |
Fri, 10 Mar 2023
Scheme Of Amalgamation Between 3B Blackbio Biotech India Limited (''Company/Transferor Company'') And Kilpest India Limited (''Transferee Company'') Scheme of Amalgamation between 3B BlackBio Biotech India Limited (Company/Transferor Company) and Kilpest India Limited (Transferee Company) |
Tue, 14 Feb 2023
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Held On Tuesday 14Th February 2023 Board Meeting Outcome for Board Meeting Held On Tuesday 14th February 2023 |
Tue, 14 Feb 2023
Investor''s Presentation Investors Presentation |
Fri, 24 Mar 2023 |
|
|
|
|
|